<- Go Home
Check-Cap Ltd.
As of August 26, 2026, Check-Cap Ltd. was acquired by MBody AI Corp., in a reverse merger transaction. Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology for the detection of precancerous colorectal polyps. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.
Market Cap
$9.3M
Volume
142.9K
Cash and Equivalents
$2.0K
EBITDA
-$2.2M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$27.44
52 Week Low
$4.35
Dividend
N/A
Price / Book Value
1.98
Price / Earnings
1.46
Price / Tangible Book Value
2.51
Enterprise Value
$9.1M
Enterprise Value / EBITDA
-4.12
Operating Income
-$2.4M
Return on Equity
416.71%
Return on Assets
-37.72
Cash and Short Term Investments
$219.0K
Debt
$16.0K
Equity
$3.4M
Revenue
N/A
Unlevered FCF
$846.9K
Sector
Health Care Equipment and Supplies
Category
N/A